Cite
HARVARD Citation
Ricco, G. et al. (n.d.). In HCV infected patients with cirrhosis Squamous Cell Carcinoma Antigen (SCCA)-IgM levels may contribute to identify the individual risk of HCC development after antiviral therapy. Digestive and liver disease. 49 (1), pp. e48-e49. [Online].